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Abstract 
Excessive accumulation of fat as the result of more energy intake and less energy expenditure is 
known as obesity. Lipids are essential components in the human body and are vital for maintaining 
homeostasis, physiological as well as cellular metabolism. Fatty acid synthesis and catabolism (by 
fatty acid oxidation) are normal part of basic fuel metabolism in animals. Fatty acids are degraded 
in the mitochondria by a biochemical process called β-oxidation in which two-carbon fragments 
are produced in each cycle. The increase in fatty acid oxidation is positively correlated with body 
mass index. Although healthy life style, avoiding Western diet, dieting and strenuous exercise are 
commonly used methods to lose weight, they are not considered a permanent solution in addition 
to risk attenuation of in basal metabolic rate (BMR). Pharmacotherapy offers benefits of weight 
loss by altering the satiety and lowering absorption of fat from the food; however, its side effects 
may outweigh the benefits of weight loss. Alternatively, dietary phytochemicals and natural health 
products offer great potential as an efficient weight loss strategy by modulating lipid metabolism 
and/or increasing BMR and thermogenesis. Specifically, polyphenols such as citrus flavonoids, 
green tea epigallocatechin gallate, resveratrol, capsaicin and curcumin, have been reported to 
increase lipolysis and induce fatty acid β-oxidation through modulation of hormone sensitive 
lipase, acetyl-coA carboxylase, carnitine acyl transferase and peroxisome proliferator-activated 
receptor gamma coactivator-1. In this review article, we discuss selected phytochemicals in 
relation to their integrated functionalities and specific mechanisms for weight loss. 
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Abbreviations 
Acetyl-CoA Carboxylase, ACC 
Acyl CoA Synthetase, ACS 
5' Adenosine Monophosphate-Activated Protein Kinase, AMPK 
Activated or phosphorylated AMPK, AMPK-P  
Body Mass Index, BMI 
Carnitine Palmitoyl Transferase, CPT 
Carnitine Palmitoyl Transferase-1, CPT-1 
Carnitine Palmitoyl Transferase-1B, CPT-1B 
Citrate Lyase, CL 
Cyclic Adenosine Monophosphate, cAMP 
DNA Methyltransferases, DNMTs 
Fatty Acid, FA 
Fatty Acid Oxidation, FAO 
Fatty Acid Synthase, FAS 
Glycerol-3-Phosphate Acyl Transferase-1, GPAT-1 
Histone Acetyltransferases, HATs 
Histone Deacetylases, HDACs 
Hormone Sensitive Lipase, HSL 
Hydroxycitric Acid, HCA 
Lipoprotein Lipase, LPL 
Mitochondrial Electron Transport Chain, ETC 
Mitochondrial Uncoupling Protein-2, UCP-2 
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Peroxisome Proliferator-Activated Receptor-Gamma, PPAR- 
Peroxisome Proliferator-Activated Receptor δ, PPARδ 
Raspberry Ketone, RK 
Respiratory Quotient, RQ 
Small Non-Coding RNAs, miRNAs 
Triacylglycerol, TAG 
Tricarboxylic Acid, TCA 
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1. Introduction 1 
The prevalence of obesity has progressively increased over the past 30 years worldwide 2 
especially in the Western countries. Obesity is a condition characterized by accumulation of 3 
excessive body fat. It is classified by body mass index (BMI) [a ratio of body weight (in kg) to 4 
height (in meter squared)] in a way where individuals with a value over 30 are considered obese 5 
(Witkamp, 2011; Bessesen, 2008). Obesity is an alarming indicator of onset of metabolic disorder 6 
which is a cluster of health complications including hypertension, type 2 diabetes and 7 
cardiovascular disease (Faulds et al., 2012; Salas-Salvado et al., 2011). Therefore, apart from 8 
personal interest, the treatment of obesity is of clinical significance.  9 
Weight management is a commonly recommended approach which is based on lifestyle 10 
modifications including dieting, increased physical activity, exercise, etc. However, physical 11 
exercise and dieting is often a difficult routine to maintain for lifetime and the results can be 12 
disappointing in long term. At present, the combination therapy of reducing calorie intake, 13 
increased energy expenditure and pharmacotherapy is becoming more popular. To this end, several 14 
drugs such as Fenﬂuramine, R-Fenﬂuramine, Temin, Sibutramine, Orlistat, Qsymia, and Belviq 15 
have been approved, by FDA, towards weight management aid. However, four of these were 16 
removed later on due to their adverse health effects (WHO, 2000). In addition, all current weight 17 
management drugs in the market have high cost as well as potential side effects thus causing 18 
dissatisfaction to the consumers. Finally, gastric surgery has had the most effective approach in 19 
severely obese to show long term effects.  20 
Despite the progress in weight management strategy in recent years, obesity still poses a 21 
serious challenge for the scientific community (WHO, 2000; González-Castejón and Rodriguez-22 
Casado, 2011). Therefore, there is considerable demand to explore natural therapies in developing 23 
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an alternative, safer and effective strategy. For this reason, a variety of natural phytochemicals 24 
have been explored for their ability to increase fatty acid oxidation, fat absorption and suppress 25 
appetite control. This review article will focus on most recent evidence on those phytochemicals 26 
that potentially increase fatty acid β-oxidation in relation to weight loss. 27 
 28 
2. Fatty acid β-oxidation and its regulation 29 
Fats are stored in our body as triacylglycerols (TAG) which are hydrolyzed into free fatty 30 
acids and glycerol by lipases as the first step of lipid catabolism. The fatty acid β-oxidation 31 
pathway consists of multistep reactions which oxidizes fatty acids by degrading two carbons at a 32 
time (Fig. 1). It takes place in mitochondria and peroxisomes, in eukaryotes, and it is a major 33 
source of energy supply by providing more energy as compared to equivalent amount of glucose. 34 
In the peroxisomes, long-chain fatty acids are converted to acyl CoA which cannot diffuse across 35 
the inner mitochondrial membrane to be utilized for the fatty acid β-oxidation pathway. Therefore, 36 
a transport system is required, called the carnitine shuttle system, catalyzed by carnitine 37 
acyltransferase-1 or carnitine palmitoyltransferase-1 (CPT-1). While in cytosol, fatty acyl CoA is 38 
converted into acylcarnitine (by carnitine acyltransferase I) which enters the mitochondrial matrix 39 
and fatty acyl CoA is regenerated by a reaction catalyzed by carnitine acyltransferase II (Horton 40 
et al., 2006). Beta-oxidation is catalyzed by the sequential action of four enzyme families: acyl 41 
CoA dehydrogenase (E1), enoyl CoA hydratase (E2), 3-hydroxy acyl CoA dehydrogenase (E3), 42 
and 3-ketoacyl CoA thiolase (E4) (Fig. 1).  43 
Acetyl-CoA carboxylase (ACC) plays as central element both in fatty acid β-oxidation and 44 
fatty acid biosynthesis. ACC catalyzes the carboxylation of acetyl-CoA producing malonyl-CoA, 45 
which can be used by fatty acid synthase for fatty acid biosynthesis. As malonyl-CoA is the 46 
8 
 
substrate for fatty acid biosynthesis, malonyl-CoA is also a direct inhibitor of mitochondrial fatty 47 
acid uptake as well as inhibition of CPT-1. 5' Adenosine monophosphate-activated protein kinase 48 
(AMPK) regulates fatty acid metabolism by phosphorylation-induced inhibition of ACC activity 49 
and eventually stimulate fatty acid β-oxidation and down-regulate fatty acid biosynthesis (Fig. 1) 50 
(Lopaschuk et al., 2010). 51 
 52 
3. Metabolic understanding of obesity 53 
Cellular energy is produced from energy sources in the mitochondria. The major two 54 
sources of energy in a human body are carbohydrates and fatty acids. The body produces energy 55 
in the form of ATP by oxidation of carbohydrates, fats and proteins through tricarboxylic acid 56 
(TCA) cycle; and by fatty acid oxidation through β-oxidation. The body derives energy for its 57 
cellular processes by breaking down ATP to ADP and AMP. Under normal conditions, more ATP 58 
is produced through β-oxidation of fatty acids in the mitochondria as compared to carbohydrates. 59 
The first requirement in fatty acid β-oxidation is the presence of fatty acyl-CoA and its transport 60 
into the mitochondria facilitated by CPT-1 (a rate-limiting step for β-oxidation) (McGarry et al., 61 
1983; Eaton et al., 2001). Malonyl-CoA (a precursor of fatty acid synthesis) is a competitive 62 
inhibitor of CPT-1 meaning that when an energy level is high, it prevents fatty acid oxidation 63 
whereas when energy level is low, malonyl and acetyl CoA levels fall and consequently β-64 
oxidation is induced by the activation of CPT-1 (Zammit et al., 1999). Therefore, the enzymes 65 
CPT-1 and fatty acid synthase (FAS) directly regulate catabolism and anabolism of fatty acids 66 
(Ronnett et al., 2005). In addition, glucose oxidation directly inhibits fatty acid oxidation in a 67 
manner characterized by an insulin dependent response where a high glucose level (after a meal) 68 
is regulated by insulin thus facilitating glucose uptake in the cells and consequently inhibiting 69 
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lipolysis and β-oxidation. Furthermore, low circulating levels of glucose and increased energy 70 
demand can both stimulate cellular fatty acid β-oxidation pathway (Smith, 1994).  71 
Obesity can lead to impaired cellular metabolism including dependence on glucose 72 
oxidation (for ATP production) and decrease in fatty acid oxidation, thus leading to more fat 73 
deposition in skeletal muscles, hepatocytes and other cells (Rogge, 2009). The reduced fatty acid 74 
oxidation can be marked relative to the respiratory quotient (RQ). This way, when energy is 75 
produced from fats (by β-oxidation) more oxygen is consumed and the RQ is low (e.g. 0.7) and 76 
alternatively, when carbohydrates are the main source of ATP generation in the body, less oxygen 77 
is consumed and the RQ is high (e.g. 1.0). Obese individuals have been reported to have high RQ 78 
values, indicating low fat oxidation and thus more dependence on glucose than lean individuals 79 
(Filozof et al., 2000; Simoneau et al., 1999). Therefore, reduced fatty acid oxidation is considered 80 
as a risk factor for the development of obesity. Other studies indicate that obese individuals have 81 
reduced CPT-1 activity, which impairs the flow of fatty acid transfer to mitochondria and hereby 82 
reduce β-oxidation, suggesting that fatty acids cannot be oxidized even after lipolysis if CPT-1 is 83 
not activated (Simoneau et al., 1999; Rogge 2009).  84 
 85 
4. Possible mechanisms of weight loss 86 
i. One of the popular approach of weight loss is through appetite control. The food urge and 87 
satiety is controlled by serotonin, histamine, dopamine and their receptors. Sibutramine is 88 
an anti-obesity drug which functions as appetite suppressant; however, coupled with 89 
various side effects such as dry mouth, constipation and insomnia (Tziomalos et al., 2009). 90 
ii. Stimulated energy expenditure can be used to reduce body weight by induction of non-91 
shivering thermogenesis. Thermogenesis is mainly regulated by leakage of protons 92 
10 
 
generated in oxidative phosphorylation, bypassing ATP generation and activating UCP-1 93 
which thereby, dissipates energy as heat (Kumar et al., 1999). UCP-1 is expressed in 94 
mitochondria-rich brown adipose tissue. Likewise, UCP-3 also mediates thermogenesis 95 
regulated by the thyroid hormone, β-adrenergic receptor agonist and leptin (Gong et al., 96 
2000). The function of UCP family was demonstrated in a mice study, where the mice 97 
over-expressing UCP-1, UCP-2 and UCP-3 were resistant to diet-induced obesity; 98 
however, they were susceptible to cold due to the lack of thermogenesis (Arsenijevic et al., 99 
2000, Gong et al., 2000).  100 
iii. Adipocytes increase in size and differentiate when fat storage increases under obesity. 101 
Thus, the compounds that inhibit adipocyte differentiation and induce apoptosis in mature 102 
adipocytes can be considered as potentially promising anti-obesity agents (Kim et al., 2006; 103 
Yun, 2010).  104 
iv. Many pharmaceutical drugs stimulate triacylglycerol hydrolysis and release fatty acids. 105 
Lipolysis diminishes storage fat (leading to dyslipidemia) thus, intervening the β-106 
adrenergic receptor agonist is required to oxidize the released fatty acids (Langin, 2006). 107 
v. In lipid metabolism, peroxisome proliferator-activated receptor gamma (PPAR-γ) and 5' 108 
adenosine monophosphate-activated protein kinase (AMPK) play crucial roles. PPAR-γ is 109 
a transcriptional factor (mediating gene expression) predominately expressed in adipose 110 
tissue that stimulates adipose differentiation. Therefore, PPAR-γ agonists can ameliorate 111 
dyslipidemia, as well as improve adiposity and insulin resistance (Cornalius et al., 1994). 112 
vi. AMPK is an enzyme which regulates the target proteins controlling metabolism. AMPK 113 
activation regulates glucose transport and fatty acid oxidation. Increase in AMPK in muscle 114 
stimulates CPT-1 production and eventually increases fatty acid oxidation (Lee et al.,  115 
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2005). Activation of AMPK by exercise and fuel deprivation (AMP:ATP ratio) have led to 116 
studies of the effects of AMPK on lipid metabolism, obesity and metabolic syndrome–117 
related diseases (O’Neill, 2013). 118 
vii. One of the most promising approaches to weight management is the decrease in fat 119 
absorption. In gastrointestinal tract, before fat gets absorbed, it is subjected to the action of 120 
pancreatic lipase with its inhibition being a clinically approved strategy for controlling 121 
obesity. One such drug compound is Orlistat; however, also associated with certain side 122 
effects like oily spotting, liquid stools, abdominal cramps, etc. (Chaput et al., 2007). 123 
viii. SIRT1 and SIRT3 belong to the sitrulin family of the silent information regulator 2 124 
enzymes which have been found to regulate insulin secretion as well as lipid metabolism. 125 
SIRT1 plays an important role in regulation of obesity during fasting and feeding 126 
(Chalkiadaki and Guarente, 2012; Guarente, 2006). Its major role is played in hepatic fatty 127 
acid metabolism, at various steps such as activation of the AMPK/LKB1 pathway thus 128 
facilitating fatty acid oxidation (Hou et al., 2008). The specific action of SIRT1 in 129 
regulating PPAR-α was demonstrated in mice studies when hepatocyte specific deletion of 130 
the SIRT1 gene led to decreased rate of fatty acid oxidation (Purushotham et al., 2009). On 131 
the other hand, SIRT3 directly regulates hydroxyacyl-CoA dehydrogenase, acyl-CoA 132 
dehydrogenases and deacetylates as well as activates acyl-CoA synthetase short-chain 133 
hereby, modulating β-oxidation (Hallows et al., 2011, Hirschey et al., 2010, Hallows et al., 134 
2006).  135 
5. Phytochemicals stimulating fatty acid β-oxidation 136 
Nutritional supplements have been claimed to increase energy metabolism, reduce fat 137 
absorption, increase fat oxidation all of which thereby increase weight loss and consequently 138 
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described popularly as fat burners (Jeukendrup and Randall, 2011). The majority of the ingredients 139 
used in these nutritional supplements are from plant origin and commonly referred as 140 
phytochemicals. These phytonutrients are secondary metabolites produced by plants and play a 141 
central role in defensive mechanism against stress, pathogens, herbivores and disease conditions. 142 
Phytochemicals are divided into polyphenols, alkaloids and isoprenoids on the basis of their basic 143 
structure and biosynthesis (Table 1). The list of phytochemicals capable of facilitating weight loss 144 
by reducing appetite suppressants and/or fat absorption is still on-growing; however, not all of 145 
them regulate fatty acid β-oxidation. Thus, it is within the scope of this review article to focus on 146 
those phytochemicals capable of influencing the β-oxidation pathway (Table 2). 147 
 148 
5.1 Epigenetic properties of phytochemicals 149 
Over the past few decades, there is a growing interest in investigating and understanding 150 
the beneficial properties of phytochemicals. A number of studies have revealed that the presence 151 
of phytochemicals is responsible for exerting a plethora of different biological effects such as 152 
antioxidant, anti-inflammatory, anti-aging, anti-proliferative, etc. To this end, after their isolation 153 
and characterisation, there is a continuously increasing trend towards promoting their utilization 154 
in various fields of biology and medicine such as drug design, disease therapy, cosmeceuticals, 155 
nutrition/dietetics, etc. (Su et al., 2013, Szarc del Szic et al., 2015). In recent years, emerging 156 
reports have provided evidence that phytochemicals can exert their advantageous effects by 157 
targeting epigenetic mechanisms via regulation of specific epigenetic components such as DNA 158 
methyltransferases (DNMTs), histone deacetylases (HDACs), histone acetyltransferases (HATs) 159 
and small non-coding RNAs (miRNAs) (Guo et al., 2015, Shankar et al., 2013). Epigenetic 160 
modifications are defined as reversible and heritable alterations in gene expression without 161 
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changes in the DNA sequence. The most common types are DNA methylation as well as histone 162 
acetylation, deacetylation and methylation all of which are capable for modulating gene 163 
expression. In addition, miRNAs have been implicated in several cellular processes while at the 164 
same time they have been shown to regulate gene expression (Sharma et al., 2010).  165 
Current research reports have outlined that there is a relation between epigenetic 166 
modifications and metabolic disorders like obesity. More specifically, evidence from a recent 167 
report showed that there are different methylation patterns of genes implicated in fatty acid β-168 
oxidation (FAO) in samples obtained from lean and severely obese women in response to lipid 169 
exposure. According to the results, there was an immediate induction of genes participating in 170 
FAO in response to lipid exposure among lean women whereas this was not observed in the case 171 
of the severely obese ones. The mRNA levels of peroxisome proliferator-activated receptor δ 172 
(PPAR-δ; a molecule participating in FAO) were found to be differentially regulated in the case 173 
of severe obesity, a fact that was attributed to different methylation patterns of the gene (Maples 174 
et al., 2015a). Moreover, data from a similar study demonstrated that the expression of carnitine 175 
palmitoyltransferase 1B (CPT-1B; a protein responsible for transferring the long-chain fatty acids 176 
across the outer mitochondrial membrane) was reduced in skeletal muscle cells isolated from 177 
severely obese women in contrast to lean women following lipid exposure. The observed 178 
differential expression of CPT-1B, in obese women, was due to alterations in DNA methylation, 179 
histone acetylation and transcription factor binding (Maples et al., 2015b). As a consequence, it is 180 
logical that the link between epigenetic modifications and obesity could be influenced by 181 
phytochemicals (given their ability to modulate key epigenetic processes); however, such link is 182 
purely speculative and yet to be established.  183 
 184 
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5.2 Classes of phytochemicals 185 
5.2.1 Green tea catechins 186 
Health benefits of regular consumption of green tea are mostly attributed to the large 187 
amount of catechins, polyphenols of flava-3-ol sub-family of flavonoids. Unlike black tea, green 188 
tea manufacturing preserves high amount of epicatechin, epigallocatechine, epicatechin-3-gallate 189 
and epigallocatechine-3-gallate (EGCG) as it is prepared from non-oxidized and non-fermented 190 
leaves. Catechins are considered to inhibit catechol-O-methyltransferase which is responsible for 191 
breaking down norepinephrine and thereby stimulate fat oxidation (Borchardt, 1975). The hepatic 192 
fatty acid oxidation and ATP production directly influence appetite by influencing appetite 193 
regulating centers of the brain. Green tea catechins can control appetite as a result of up-regulation 194 
of hepatic fat oxidation and ATP generation (Friedman 2007; Kamphuis et al., 2003).  195 
Green tea catechins have been supported as fat burning phytochemicals in various animal 196 
studies; however, the clinical evidence is still lacking behind in confirming these findings. For 197 
instance, results from a study using obese C57BL/6J mice showed that green tea-EGCG had the 198 
ability to induce body mass reduction while it also caused changes in the mRNA expression levels 199 
of PPAR-γ, C/EBP-α, SREBP-1c, aP2, LPL and FAS all of which decreased in white adipose 200 
tissue. On the other hand, the mRNA levels of CPT-1, UCP2, HSL and ATGL increased (Lee et 201 
al., 2009). Additionally, another study associated the supplementation of green tea catechins in the 202 
diet of lactating maternal rats with the increase of mRNA expression levels of DNMT1, DNMT3a, 203 
SIRT1 and SIRT2 in the kidneys of their three week old offspring. This, in turn, supports the 204 
correlation between maternal levels of catechins and increased levels of enzymes (in newborn 205 
female offspring) capable of influencing epigenetic marks capable of potentially regulating energy 206 
metabolism (Sun et al., 2013). In a recent study, addition of 1% green tea to high-fat diet of mice 207 
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has reduced mass of adipose tissue and TAG, glucose, insulin, and leptin levels of blood (Lee et 208 
al., 2015). It was postulated that green tea has the ability of modulation of abnormal fatty acid –209 
oxidation caused by high-fat diet.  210 
Beneficial effects of combined flavonoids on diet-induced obesity have been demonstrated. 211 
Recently, supplementation of flavonoids from green tea combined with cocoa, coffee and Garcinia 212 
has shown to stimulate lipid metabolism in high-energy diet-induced obese rats, which is 213 
attributable to fat mobilization from adipose tissue (Huang et al., 2016). A recent review on dietary 214 
polyphenols and obesity also confirmed that green tea catechins (especially EGCG), resveratrol 215 
and curcumin all exert anti-obesity properties (Wang et al., 2014). 216 
 217 
5.2.2 Resveratrol 218 
Resveratrol (3,4,5-trihydroxystilbene) is a naturally occurring stilbene sub-group of 219 
polyphenol in grapes, red wine and some berries (Freemont, 2000). It has been studied for its 220 
involvement in regulating fatty acid β-oxidation in relation to preventing degradation of 221 
intracellular cyclic adenosine monophosphate (cAMP) through inhibition of cAMP 222 
phosphodiesterase enzymes which in turn activate the AMPK enzyme (Park et al., 2012a, Chung, 223 
2012a,b), which consequently activates mitochondrial biogenesis and function by activating PGC-224 
1α (Wu et al., 1999). A recent review has also revealed that anti-obesity activity of resveratrol 225 
could also be through down-regulation of PPAR-, CCAAT-enhancer-binding protein (C/EBPα), 226 
and sterol regulatory element binding protein 1c (SREBP-1c) (Aguirre eta l., 2014). In an another 227 
resveratrol supplementation (0.02% of diet) study conducted using ApoE-deficient mice, 228 
resveratrol exerts not only anti-obesity and hypolipidemic effects, but also protective effects for 229 
the liver and aorta through the modulation of lipid metabolism in liver and white adipose tissue 230 
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(Jeon et al., 2014). In addition, resveratrol has been proposed as a natural SIRT-1 activator which 231 
can also further activate PGC-1α (Lagouge et al., 2006). Moreover, in several animal studies, the 232 
supplementation of resveratrol resulted in a remarkable increase of AMPK activity (Baur et al., 233 
2006; Shang et al., 2008b; Rivera et al., 2009). Exposure to resveratrol has reported to increase 234 
fatty acid β-oxidation in CPT-II and very long chain acyl CoA dehydrogenase deficient cultured 235 
patient fibroblast model (Aires et al., 2014). In another study, resveratrol increased fatty acid β-236 
oxidation by inhibiting the production of malonyl-CoA (Szkudelska and Szkudelski, 2010). 237 
Animal studies have demonstrated the role of resveratrol in energy expenditure in a way 238 
where animals were capable of surviving cold longer with supplementation of high doses of 239 
resveratrol than untreated ones (Lagouge et al., 2006). Similar observations were recorded after 240 
one year of treatment with resveratrol (200 mg/kg/day) where such treatment was found to increase 241 
basal metabolic rate and total daily energy expenditure in the non-human primate Microcebus 242 
murinus (Dal-Pan et al., 2010; Dal-Pan et al., 2011). These studies further strengthen the capacity 243 
of resveratrol to enhance energy expenditure and potentially promote weight loss. Only recently, 244 
resveratrol has become the subject of intense research as being a phytochemical associated with a 245 
great range of health promoting properties. For this reason, it has attracted the attention of the 246 
nutraceutical industry as it is consumed by two-thirds of consumers taken dietary nutritional 247 
supplements (Block et al., 2007). 248 
Finally, according to the findings from a recent report, the combined administration of 249 
resveratrol and pterostilbene (in rats) resulted in preventing the up-regulation of the FAS gene 250 
(induced in response to a high fat and sucrose contained diet) while pterostilbene was also 251 
demonstrated to be responsible for the differential methylation pattern of the gene as well (Gracia 252 
et al., 2014). 253 
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 254 
5.2.3 Capsaicinoids 255 
Red hot chillies or peppers are a commonly used spice in food worldwide. Capsaicinoid is 256 
the class of pungent polyphenol derivative compound in red chillies. The genus capsicum includes 257 
more than 200 varieties and concentration of capsaicin also varies (0 - 13,000 mg/kg) (Kozukue et 258 
al., 2005). Capsaicin (N-[(4-hydroxy-3-methoxyphenyl)-methyl]-8-methyl-6-nonamide) is the 259 
pungent compound which has been reported to increase thermogenesis and secretion of 260 
catecholamines from adrenal medulla (Watanbe et al., 1987) which stimulate adrenergic receptors 261 
in liver and adipose tissue resulting in lipolysis and energy expenditure (Diepvens and Westerterp, 262 
2007). A meal containing red pepper instantaneously increases energy expenditure in humans 263 
(Yoshioka et al., 1995). Although supplementation with capsaicinoids has been reported to 264 
increase BMR in human subjects by increasing fat oxidation (Lejeune et al., 2003) they cannot be 265 
generally consumed in high dosages due to their strong pungency and nociceptive stimulus. 266 
However, capsiate (a non-pungent capsaicinoid analogue derived from Capsicum annuum L.; CH-267 
19 Sweet) has been reported to increase body temperature and increase mRNA and protein levels 268 
of uncoupling proteins (UCPs) of brown adipose tissues in a two-week mice study (Masuda et al., 269 
2003). The thermogenic effects of capsaicin are attributed to its structure and not its pungency 270 
(Ohnuki et al., 2001a). Similarly, there was an increase in catecholamine and free fatty acid levels 271 
together with a decrease in triacylglycerol levels resulting in elevated levels of fat oxidation in 272 
mice after supplementation with a single oral dosage of capsiate (Ohnuki et al., 2001b; Haramizu 273 
et al., 2006).  274 
CPT-1α is the rate-limiting enzyme in mitochondrial β-oxidation and a target for reducing 275 
body fat (McGarry and Brown, 1997). On the other hand, UCP-2 is a mitochondrial proton 276 
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transporter and has been suggested to influence body temperature, energy expenditure and fat mass 277 
(Rousset et al., 2004). Capsaicin is reported to stimulate lipolysis by mediating CPT-1α and UCP-278 
2 in adipocytes (Lee et al., 2011). Capsaicin-induced thermogenesis is proposed to function 279 
through stimulation of β-adrenergic receptors as various studies have demonstrated decreased 280 
thermogenesis after administration of β-adrenergic blockers (Kawada, 1986). In a combination 281 
study of capsaicin with green tea, a decrease in fat mass was observed (Tsi et al., 2003); however, 282 
long term supplementation of capsaicin is found to be more effective in weight loss (Lejeune et 283 
al., 2003). CH-13 Sweet has similar capsaicin structure and is more suitable for long term use by 284 
maintaining effectiveness and without pungency (Reinbach et al., 2009). Furthermore, only 285 
recently, another study has demonstrated a different approach to minimize the pungency of 286 
capsaicin (and thus increase the possibility of its long term use) by preparing chitosan 287 
microspheres (Tan et al., 2014). Chitosan is a polysaccharide extracted from crab shells and it aids 288 
to overcome strong pungent taste and smell of capsaicin. Finally, the findings of a study using rats 289 
demonstrated that the administration of capsiate resulted in a reduced abdominal fat volume and 290 
body weight gain, which were associated with the differential gene expression levels of UCP3 and 291 
more specifically a reduction in its mRNA levels (Faraut et al., 2009). 292 
 293 
5.2.4 Citrus flavonoids 294 
These are a class of polyphenols found in citrus. Naringin and hesperidin belong to 295 
flavanone sub-group and nobiletin and tangeretin to O-polymethoxylated flavones. In animal 296 
studies, supplementation of naringin (3%) and nobiletin (0.3%) with high fat diet has demonstrated 297 
increase in fatty acid oxidation by up-regulating CPT-1α production (Mulvihill et al., 2009; 298 
Mulvihill et al., 2011; Jung et al., 2006). Interestingly, dietary supplementation of citrus peel 299 
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flavonoid extract (rich in nobiletin, tangeretin, rutin and hesperidin) to high-fat diet-induced obese 300 
C57BL/6 mice revered the suppressed activities of AMPK and ACC (Kang et al., 2012). In mature 301 
3T3-L1 adipocytes, the citrus peel flavonoid extract increased AMPK and ACC phosphorylation 302 
and also enhanced lipolysis by phosphorylation of cAMP-dependent protein kinase (PKA) and 303 
hormones-sensitive lipase (HSL) (Kang et al., 2012). 304 
Apart from the citrus flavonoids, the alkaloid synephrine is also a bioactive component of 305 
bitter orange (Citrus aurantium). The fruit is also often used for herbal medicine as appetite 306 
suppressant. Bitter orange alkaloids act as adrenergic agonists with octapamine and synephrine 307 
being similar to epinephrine and norepinephrine, respectively. Para-synephrine has properties of 308 
both α-adrenergic and β-adrenergic agonists and is also known as oxedrine. Its anti-obesity effects 309 
are proposed to be due to its action on β3-receptors and increased thermogenesis leading to β-310 
oxidation (Arbo et al., 2008). On the other hand, in a rat study, bitter orange extracts with 4-6% 311 
synephrine decreased body weight after 7 days (Calapai et al., 1999). However, there is a little 312 
evidence reported the ability of synephrine for weight loss in human. 313 
Finally, according to a research report, naringenin (a grapefruit flavonoid) is capable of 314 
regulating the activation of PPARα and PPARγ, while it is also responsible for the induction of 315 
several genes in fatty acid oxidation including CYP4A11, ACOX, UCP1 and ApoAI in 316 
hepatocytes (Goldwasser et al., 2010). Data from a similar study showed that the administration 317 
of naringenin, in rats, led to a differential regulation of the expression levels of PPARα, CPT1 and 318 
UCP2, with the up-regulation of PPARα consequently resulting in the increase of CPT1 and UCP2 319 
expression levels (Cho et al., 2011). As well, Huong et al. (2006) has also demonstrated that 320 
naringenin (1% of the diet) increases hepatic fatty acid oxidation through up-regulation of gene 321 
expression of enzymes involved in peroxisomal -oxidation in mice. 322 
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 323 
5.2.5 Piperine 324 
This is a pungent lipophilic alkaloid found in black pepper which is prepared from ground 325 
unripe berries from the plant Piper nigrum Linn. Piperine has been found to increase 326 
catecholamine secretion (particularly epinephrine) from the adrenal medulla in rats. These effects 327 
are similar to capsaicin but not as much potent. This effect can be described as a sympathetic 328 
nervous system (SNS)-mediated thermogenesis given that it is diminished after administration of 329 
cholinergic blockers (Kawada et al., 1984). Finally, piperine was shown to inhibit the 330 
differentiation of 3T3-L1 cells to adipocytes as it induced the down-regulation of PPARγ, SREPB-331 
1c and C/EBPβ and thus implying its potentially beneficial use in the treatment of metabolic 332 
disorders (Park et al., 2012b). 333 
 334 
5.2.6 Anthocyanins 335 
These are well-known phytochemicals for their antioxidant effects. Apart from dietary 336 
antioxidants, they also have several biological activities including anti-convulsant, anti-337 
carcinogenic, anti-atherosclerotic, anti-diabetic and anti-inflammatory thus reducing the risk of 338 
disease and in particular coronary heart disease (Drenska et al., 1989; Satue-Gracia et al., 1997; 339 
Wang et al., 1999; Koide et al., 1997; Sancho et al., 2012). Recently, studies have documented the 340 
role of anthocyanins as anti-obesity agents (Tsuda et al., 2003; Jayaprakasam et al., 2006; Matsui 341 
et al., 2001; Kwon et al., 2007). Anthocyanins are water-soluble compounds widely found in fruits 342 
and vegetables and responsible for most of the red, purple, and blue colors exhibited by flowers, 343 
fruits, and other plant tissues (Castañeda et al., 2009). In the last decade, anthocyanins from purple 344 
corn (Zea mays L.), blood orange (Citrus sinensis L.Osbeck), strawberries (Fragaria ananassa), 345 
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blueberries (Vaccinium angustifolium), blackberries (Rubus species) and mulberry (Morus 346 
australis P.) have been reported to exhibit anti-obesity effects in various in vivo studies (Tsuda et 347 
al., 2003; Titta et al., 2010; Prior et al., 2008; Prior et al., 2012; Kaume et al., 2012; Wu et al., 348 
2013a).  349 
In addition, other studies have suggested that treatment with anthocyanin induced ACC 350 
phosphorylation and increased mitochondrial fatty acid oxidation via the allosteric regulation of 351 
CPT-1, which catalyses the entry of long-chain fatty acyl-CoA into mitochondria in HepG2 cells. 352 
Therefore, a decrease in malonyl CoA levels is directly responsible for increase in CPT-1 353 
expression, leading to fatty acid oxidation (Hurley et al., 2005). On the other hand, AMPK 354 
regulates the enzymes of lipid metabolism and also directs fatty acid both in oxidative and 355 
biosynthetic pathways in the liver (Kahn et al., 2005). AMPK knockdown failed to stimulate 356 
AMPK and reduce hepatocellular lipid accumulation. Thus, the possible mechanism of 357 
anthocyanin-induced fatty acid oxidation is via AMPK directed inhibition of ACC and FAS which 358 
are two key downstream regulators of AMPK in the control of lipid metabolism. A recent study, 359 
in mice, has demonstrated down-regulation of CPT-1 gene expression after supplementation with 360 
anthocyanin-rich blueberry and mulberry juices, indicating an anthocyanin-induced stimulation of 361 
fatty acid oxidation while inhibiting fatty acid synthesis (Wu et al., 2013b). In addition, evidence 362 
from a current report further supports the ability of anthocyanins to differentially regulate various 363 
genes participating in fatty acid oxidation (e.g. PPAR-α, PPAR-δ, UCP-2, UCP-3, mitochondrial 364 
transcription factor A) as their mRNA levels were considerably increased when C57BL/6J mice 365 
were fed a high in fat and cholesterol diet with a polyphenol-rich blackcurrant extract (Benn et al., 366 
2014).  367 
 368 
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5.2.7 Curcumin 369 
This is the main bioactive polyphenol (hydroxycinnamic acid derivative) present in the 370 
rhizome of turmeric (Curcuma longa) which is commonly used as dietary spice and food color in 371 
Asian countries. In addition, it has been found to regulate signal transduction and gene expression 372 
apart of its anti-inflammatory and antioxidant properties and thus of potential benefit in disease 373 
prevention and therapy (Ohara et al., 2009; Zingg et al., 2013). Furthermore, an animal study has 374 
demonstrated that curcumin reduced the body weight gain in high fat fed mice without altering 375 
food intake in addition of influencing energy metabolism and fatty acid β-oxidation in adipocytes, 376 
through AMPK (Ejaz et al., 2009). Likewise, curcumin facilitated β-oxidation in in vitro 377 
experiments (by up-regulation of CPT-1) and reduced lipid biosynthesis (by down-regulation of 378 
glycerol-3-phosphate acyl transferase-1; GPAT-1 and acyl-CoA carboxylase) (Ejaz et al., 2009). 379 
Finally, another suggested mechanism of fatty acid oxidation, by curcumin, can be explained in 380 
terms of an increase in mitochondrial biogenesis by activation of PGC-1 (Chung et al., 2012a,b; 381 
Zingg et al., 2013).  382 
On another note, curcumin i) inhibits lipogenic enzymes in liver, ii) stimulates lipid 383 
mobilization from adipose tissue by activating HSL, iii) inhibits fatty acid synthase (FAS) activity 384 
and iv) activates fatty acid β-oxidation (Prakash and Srinivasan, 2012; Zhao et al., 2011; Jang et 385 
al., 2008). In particular, curcumin has been shown to specifically down-regulate FAS leading to 386 
an effective decrease in fat storage. Thus, there is substantial evidence to suggest that curcumin is 387 
effective in inhibiting lipid synthesis and storage as well as stimulating fatty acid degradation 388 
(Smith, 1994). To this end, data from a recent in vitro study demonstrated that curcumin was able 389 
to reduce the mRNA levels of DNMT3B suggesting its ability to affect epigenetic mechanisms 390 
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thus leading to altered gene expression (Jiang et al., 2015), a fact that might account for curcumin's 391 
observed beneficial effects in weight loss and activation of fatty acid degradation.  392 
 393 
5.2.8 Raspberry ketons 394 
Raspberry ketones [4-(4-hydroxyphenyl) butan-2-one; RK] are major phenolic acid 395 
derivative compounds present in red raspberry (Rubus idaeus) and are responsible for the sweet 396 
aroma of raspberries. Like other berries, raspberry has also been reported to have significant 397 
biological effects (Ravai, 1996). RKs have similar structures with capsaicin and synephrine, which 398 
are known for their active role in obesity and lipid metabolism (Harada et al., 2008).  399 
RKs’ supplementation inhibits body weight gain in high fat-fed rats as they are unable to 400 
bind beta-adrenergic receptors and do not trigger lipolysis in the absence of norepinephrines. 401 
Therefore, RKs can stimulate norepinephrine-induced lipolysis by facilitating the translocation of 402 
HSL from the cytosol to the lipid droplets in the fat cells in addition to increasing fat oxidation 403 
and energy expenditure by stimulating thermogenesis (Morimoto et al., 2005). In another study, 404 
treatment with 10 μM of RK induced lipolysis, fat oxidation and increased the adiponectin levels 405 
in cultured 3T3-L1 pre-adipocytes all of which led to decreased fat mass in adipocytes and 406 
potentially have a key role in body weight regulation (Park, 2010). According to the literature, 407 
administration of adiponectin increases fat oxidation in obese mice circulating free fatty acid levels 408 
by enhancing skeletal muscle fat oxidation (Wolf, 2003; Mullen et al., 2007). The other suggested 409 
mechanism of RK regulated fat loss can be through reversing leptin resistance and elevating 410 
PPAR-α (Meng et al., 2008; Wang et al., 2012). Leptin is a hormone secreted by adipocytes which 411 
stimulate fatty acid oxidation by induction of AMPK (Monokoshi et al., 2002).  412 
 413 
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5.2.9 Cocoa polyphenols 414 
Cocoa is a major ingredient of chocolate and it is derived from the beans of the Theobroma 415 
cacao (Baba et al., 2000). The cocoa beans consist of approximately 6-8% polyphenols (by weight) 416 
with their presence contributing to dark chocolate being a rich source of antioxidants. These are 417 
predominantly flavonoids and mainly epicatechin, catechin and proanthocyanidins with a small 418 
amount of quercetin also present (Manach et al., 2004; Andres-Lacueva et al., 2008). Polyphenol-419 
rich cocoa extracts possess many bioactivities including anti-hyperlipidemic (Hamed et al., 2008), 420 
anti-diabetic (Grassi et al., 2005), antioxidant (Galleanoet al., 2009), in addition to improving 421 
cognitive and visual performance (Field et al., 2011) and boosting the immune system (Katz et al., 422 
2011). 423 
Genistein, which is the main isoflavone in cocoa extract, directly interacts with PPAR-α 424 
and PPAR-γ and functions as an activator for stimulating fatty acid catabolism (Kim et al., 2004a; 425 
Kim et al., 2004b). Furthermore, activation of PPAR-α is reported to stimulate the expression of 426 
β-oxidation genes, including CPT-1, ACO and UCP3. Adiponectin expression also increases with 427 
the activation of PPAR-γ (Maeda et al., 2001) in addition to activating the AMPK pathway which 428 
regulates glucose and lipid metabolism (Arts and Hollman, 2005; Kurlandsky and Stote, 2006). 429 
Finally, cocoa polyphenols have been reported to increase plasma adiponectin levels and also 430 
increase thermogenesis through activation of the AMPK pathway and specifically via up-431 
regulation of UCPs which are involved in facilitating thermogenesis and energy expenditure 432 
(Yamashita et al., 2012; Corti et al., 2009). 433 
Even though various studies have mentioned different types of cocoa flavonoids, it is not 434 
evident yet which phytochemicals are efficacious for exerting their anti-obesity (Farhat et al., 435 
2014). Nogueira et al., (2011) reported that the supplementation of 2 mg/kg/day of cocoa-derived 436 
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epicatechin stimulated fat oxidation whereas in another study, supplementation with a dose of 437 
cocoa (containing 18.4 mg epicatchin and 380 mg of polyphenols and equivalent to 40 g/day in 438 
humans) exhibited anti-obesity effects in mice (Gu et al., 2014). Moreover, the weight reducing 439 
effects of dark chocolate can be partially attributed to caffeine which is present in significant 440 
amount (Stark et al., 2006; Zheng et al., 2004). Findings from a very recent study demonstrates 441 
that cocoa polyphenol administration in the diet of Sprague-Dawley rats resulted in the 442 
differentially regulated expression of genes implicated in lipid metabolism in mesenteric white 443 
adipose tissue, as the mRNA levels of several lipolysis enzymes were found to be increased (Ali 444 
et al., 2015). Finally, further studies support the ability of cocoa polyphenols to affect DNA 445 
methylation patterns of peripheral leukocytes in subjects with cardiovascular risk factors including 446 
obesity (Crescenti et al., 2013).  447 
 448 
5.2.10 Soybean phytochemicals 449 
Soybeans (Glycine max) are consumed mainly as a source of protein, besides being also rich 450 
in micronutrients such as isoﬂavones, phytate, soyasaponins, phytosterol, vitamins and minerals 451 
(Rupasinghe et al., 2003). They are known to be the richest source of isoﬂavones in food (Cederroth 452 
and Nef, 2009) whereas soya-derived phytoestrogens (non-steroidal plant-derived compounds 453 
which can bind estrogen receptors and thus mimic estrogen) have been shown to exert beneficial 454 
effects in cardiovascular disease, diabetes, osteoporosis and prostate cancer (Setchell, 1998; Tham 455 
et al., 1998; Sacks et al., 2006; Kuiper et al., 1997). Soybean isoﬂavones have been the subject of 456 
intense research and thus shown to exert estrogenic effects hence influencing glucose and lipid 457 
metabolism (Velasquez and Bhathena, 2007). Various animal studies have demonstrated that a soya-458 
rich diet significantly reduces fat accumulation (Bu et al., 2005; Lephart et al., 2004) and increases 459 
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energy expenditure and locomotor activity by utilizing lipid resources (Cederroth et al., 2007; 460 
Cederroth et al., 2008). In a study of high-fat diet-induced obesity in C57BL/6 mice, 461 
supplementation of fermented black soybean has significantly lowered the body and liver weight 462 
and the levels of blood glucose, total cholesterol and leptin (Oh et al., 2014). Similarly, when high 463 
fat-diet is supplemented with 0.15% of kaempferol glycosides isolated from soybean leaves, body 464 
and adipose tissue weight and blood TAG of C57BL/6J mice were reduced significantly. 465 
Furthermore, expression of genes of PPAR- and SREBP-1c was also reduced by the diet 466 
supplementation of soybean flavonoids (Zang et al., 2015). 467 
Although the anti-obesity effect of soya isoflavones is well-evident, the exact mechanism 468 
remains unclear. To this end, suggested mechanisms include correlation of decrease of adiposity 469 
with increase in AMPK and ACC activation (Hwang et al., 2005) along with increased lipolysis 470 
through inhibition of cAMP phosphodiesterases (Szkudelska et al., 2000). The up-regulation of 471 
AMPK, PPAR-γ co-activator-1α (PGC-1α) and PPAR-α resulted in increased β-oxidation and 472 
energy expenditure (Cederroth et al., 2007; Cederroth et al., 2008). Although speculative, it may be 473 
that such gene up-regulation is the result of the induction of epigenetic mechanisms as recently, a 474 
study utilizing monkeys showed the presence of epigenetic alterations (by means of altered DNA 475 
methylation patterns) induced when a high in fat content of a soy-based diet was changed to one 476 
without soy (Howard et al., 2011).  477 
 478 
5.2.11 Hydroxycitric acid 479 
Hydroxycitric acid (HCA), an organic acid, is one of widely known supplements for anti-480 
obesity and weight management. G. cambogia extract is a commercially available and richest source 481 
of HCA that contributes to anti-obesity mainly by suppressing appetite (Leonhardt et al., 2002), 482 
27 
 
inhibiting de novo lipogenesis (Kovacs et al., 2006) and increasing fat oxidation (Preuss et al. 2004). 483 
In addition, another suggested mechanism is reduction of the acetyl-CoA by HCA and thus, 484 
eventually inhibiting lipogenesis by regulating the availability of precursors for fatty acid and 485 
cholesterol biosynthesis (Chuah et al., 2013). In addition, a study by Ishihara et al., (2000) conducted 486 
in mice suggested that chronic HCA administration increased fatty acid oxidation during a 3-week 487 
experimental period. Moreover, another study determined increase in HCA-induced fatty acid 488 
oxidation by means of measuring urinary concentration of fatty acid oxidation by-products (Preuss 489 
et al., 2004).  490 
Although, currently there are no reports supporting the contribution of HCA in regulating 491 
the expression of genes involved in FAO, a recent study showed that cambogin (a compound from 492 
the Garcinia genus) was responsible for inducing epigenetic changes (via an increase in the 493 
trimethylation of histone H3K9) in a different experimental setting and in order to exhibit its anti-494 
proliferative effects in various human breast cancer cell lines (Shen et al., 2015). Nevertheless, to 495 
this end, other compounds of G. cambogia, like HCA, might also exhibit an ability to induce 496 
epigenetic alterations in the context of anti-obesity and consequently management of weight control.  497 
 498 
6. Conclusions 499 
There is a vast majority of numerous phytochemicals being the subject of intense research 500 
as potentially efficient dietary agents for the management of weight control. However, only some 501 
of them are directly involved in weight reduction by stimulation of fatty acid β-oxidation. To this 502 
end, the phytochemicals enlisted in this review have demonstrated the capacity for weight loss in 503 
both cell-based assays and pre-clinical studies. Even though the clinical evidence is very limited, 504 
these plant-based compounds have been traditionally used for their anti-obesity benefits without any 505 
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toxicity or health hazard concerns. Most of these phytochemicals, apart from their weight loss 506 
properties, also have other additional health benefits including anti-inflammatory, antioxidant and 507 
other biological functions. Overall, the benefit of weight loss leads to reduction in fat mass, decrease 508 
in inflammation and further reduction of the risk of developing metabolic disease. In addition, it 509 
should be noted that there is also evidence to support a role of phytochemicals in regulating the 510 
differential expression of various genes, implicated in various cellular pathways through epigenetic 511 
mechanisms. Although the current evidence is substantially speculative, the fatty acid β-oxidation 512 
pathway can be one such target pathway the significance of which is of extreme importance given 513 
its relevance to weight loss and the overall management of weight control. 514 
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Table 1: Classification of major phytochemicals 
Phytochemicals Examples 
Polyphenols Anthocyanins, flavonols, catechins, isoflavonoids, flavones, flavanones, 
stilbenes, phenolic acids, capsaicinoids, curcuminoids 
Alkaloids Caffeine, nicotine, piperine 
Isoprenoids Beta-carotene, lycopene, essential oils 
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Table 2: Structure of phytochemicals and their sources 
Phytochemicals 
 
Structure Source Effect on β-
oxidation 
Catechin 
Epicatechin 
Epigallocatechin 
 
Green tea, 
Cocoa 
catechol-O-
methyltransferase 
Resveratrol (3,4,5-
trihydroxystilbene) 
 
Grapes, Red 
wine 
SIRT1,                          
AMPK 
Malonyl CoA 
 
Capsaicin (N-[(4-
hydroxy-3-
methoxyphenyl)-
methyl]-8-methyl-6-
nonamide) 
 
Red chillies β-adrenergic 
receptors 
CPT-1, UCP-2 
 
Naringin 
 
Citrus CPT-1α  
Nobiletin 
 
Citrus CPT-1α 
Octapamine  
 
Bitter orange β-adrenergic 
agonist 
Synephrine 
 
Bitter orange β-adrenergic 
agonist 
Piperine 
 
Black pepper SNS-mediated 
thermogenesis 
Anthocyanins 
 
Purple corn, 
Blueberry, 
Strawberry, 
Bitter orange 
Pomegrant 
CPT-1, 
AMPK 
Raspberry ketones 
(4-(4-hydroxyphenyl) 
butan-2-one)  
Raspberry PPAR-α, 
AMPK 
HSL 
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Genistein isoflavones 
 
 
Soyabeans, 
Cocoa 
AMPK,  
adiponectin,  
PPAR-α, 
CPT 
Curcumin 
 
Turmeric  CPT-1 
FAS 
 
(-)Hydroxycitric Acid 
 
Garcinia 
cambogia 
Acetyl-CoA 
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Figure Legends 
 
Figure 1: Key elements involved in the regulation of fatty acid β-oxidation at various steps.  
ACC, acetyl CoA carboxylase; ACS, acyl CoA synthetase; AMPK-P, phosphorylated AMP-
activated protein kinase; CL, citrate lyase; CPT, carnitine palmitoyl transferase; ETC, 
mitochondrial electron transport chain; E1, acyl CoA dehydrogenase; E2, enoyl CoA hydratase; 
E3, 3-hydroxy acyl CoA dehydrogenase; E4, 3-ketoacyl CoA thiolase; FA, fatty acid; FAS, fatty 
acid synthase; HSL, hormone-sensitive lipase; PPAR-δ, peroxisome proliferator-activated 
receptor δ; TAG, triacylglycerol; TCA, tricarboxylic acid; UCP-2, mitochondrial uncoupling 
protein-2. 
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